Mobility Assessment in Stroke Patients

NCT ID: NCT04728997

Last Updated: 2021-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-03

Study Completion Date

2021-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke ranks 3rd among disability-causing diseases worldwide. Following a stroke, loss of lower extremity motor function causes serious gait disturbances. The walking activity is the basis for daily and social engagement activities. Mobility (locomotion) ability; gait analysis can be evaluated with tests and reports examining walking performance. ABILOCO is also a questionnaire developed by Caty et al., evaluating mobility and locomotion in individuals after stroke. The aim of this study is; To investigate the validity and reliability of the Turkish version of the ABILOCO questionnaire developed to evaluate mobility in patients with stroke. The sample of the study will be literate individuals who have had a stroke who applied to the Neurology Unit of Ankara Hacettepe University Faculty of Physical Medicine and Rehabilitation.

Demographic information of the cases will be recorded. ABILOCO questionnaire will be adapted to Turkish. The validity and reliability comparison of the ABILOCO questionnaire with the Berg Balance Scale and Timed Get Up and Go Test will be performed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The sample of the study will consist of literate individuals who applied to Ankara Hacettepe University Faculty of Physical Medicine and Rehabilitation, Physiotherapy and Rehabilitation Department and were diagnosed with stroke. The number of cases in the study will be determined as 5 to 10 times the number of items in the questionnaire, and 65-130 individuals will be included.

Inclusion Criteria:

* Having a definite stroke diagnosis
* Those who have stable post-stroke systemic findings
* Mini-mental test score of 24 and above
* Those who can walk 10 meters unsupported
* Those who passed 2 months after stroke.

Criteria for exclusion from the study:

\- Having musculoskeletal problems that affect the mobility of the individual.

The study will use ABILOCO, which has been validated for individuals with stroke. Permission was obtained from Gilles D. Caty, the development of the questionnaire, to conduct translation and validity and cultural adaptation stduies into Turkish. In the study, firstly, the original English version of the questionnaire will be translated into Turkish by two professional translators independent of the study, and then it will be translated back into its original language English by two native English speakers who do not have a medical background. Translators will be brought together to discuss the two obtained versions of the questionnaire. The latest version of the questionnaire will be translated into the native language of the inventory and its compliance will be checked. Mini-Mental Test will be applied to determine the cognitive status of the participants. Berg Balance Scale and Timed Get Up and Go Test will be applied for mobility assessment. After that, the ABILOCO questionnaire will be applied to the participants. In order to test the reliability of the survey, the survey will be repeated 7 days later. Informed consent will be obtained from each participant regarding their voluntary participation in the study and their sociodemographic information will be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* having a definite stroke and have passed 2 months post-stroke
* individuals who can walk 10 meters without support
* Those whose systemic findings are stable after stroke
* Mini-mental test score of 24 and above

Exclusion Criteria

* Those with musculoskeletal system problems that will affect the individual in terms of mobility
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Esra Keski̇n

Research Asistant, MSc

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ESRA KESKİN

Role: PRINCIPAL_INVESTIGATOR

Study Principal İnvestigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hacettepe Üniversitesi

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EKeskin

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Monitoring Using ICF
NCT06753877 COMPLETED NA
Gait Training for Persons With Stroke
NCT00612300 COMPLETED EARLY_PHASE1